Teladoc Health (NYSE:TDOC) Shares Gap Up – Should You Buy?

Teladoc Health, Inc. (NYSE:TDOC) gapped up before the market opened on Thursday . The stock had previously closed at $9.03, but opened at $9.25. Teladoc Health shares last traded at $9.59, with a volume of 2,357,100 shares.

Analysts Set New Price Targets

A number of equities analysts have recently commented on TDOC shares. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research report on Thursday, February 27th. The Goldman Sachs Group dropped their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a research report on Monday, March 3rd. Piper Sandler decreased their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating for the company in a research report on Thursday, February 27th. Bank of America increased their target price on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a report on Wednesday, February 12th. Finally, Royal Bank of Canada lifted their price target on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $11.26.

Teladoc Health Stock Performance

The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The stock has a fifty day moving average price of $10.62 and a 200-day moving average price of $9.61. The firm has a market cap of $1.59 billion, a price-to-earnings ratio of -1.59 and a beta of 1.27.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). The firm had revenue of $640.49 million during the quarter, compared to analyst estimates of $639.44 million. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. On average, analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the business. Versant Capital Management Inc grew its holdings in shares of Teladoc Health by 313.8% in the 4th quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after acquiring an additional 2,441 shares during the period. Whipplewood Advisors LLC acquired a new stake in Teladoc Health in the fourth quarter valued at $29,000. Lindbrook Capital LLC increased its position in shares of Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after buying an additional 1,612 shares in the last quarter. Sterling Capital Management LLC raised its stake in shares of Teladoc Health by 776.7% during the 4th quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock worth $42,000 after buying an additional 4,101 shares during the last quarter. Finally, Pilgrim Partners Asia Pte Ltd acquired a new position in shares of Teladoc Health during the 4th quarter worth $60,000. Hedge funds and other institutional investors own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.